Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
A new nasal drug has been approved to treat depression. The drug Spravato is a nasal spray made by Johnson and Johnson.
Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback